{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T14:26:43Z","timestamp":1784557603635,"version":"3.55.0"},"reference-count":196,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T00:00:00Z","timestamp":1633996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPM"],"abstract":"<jats:p>Disorders of gut\u2013brain interactions (DGBIs) are heterogeneous in nature and intertwine with diverse pathophysiological mechanisms. Regular functioning of the gut requires complex coordinated interplay between a variety of gastrointestinal (GI) cell types and their functions are regulated by multiple mechanisms at the transcriptional, post-transcriptional, translational, and post-translational levels. MicroRNAs (miRNAs) are small non-coding RNA molecules that post-transcriptionally regulate gene expression by binding to specific mRNA targets to repress their translation and\/or promote the target mRNA degradation. Dysregulation of miRNAs might impair gut physiological functions leading to DGBIs and gut motility disorders. Studies have shown miRNAs regulate gut functions such as visceral sensation, gut immune response, GI barrier function, enteric neuronal development, and GI motility. These biological processes are highly relevant to the gut where neuroimmune interactions are key contributors in controlling gut homeostasis and functional defects lead to DGBIs. Although extensive research has explored the pathophysiology of DGBIs, further research is warranted to bolster the molecular mechanisms behind these disorders. The therapeutic targeting of miRNAs represents an attractive approach for the treatment of DGBIs because they offer new insights into disease mechanisms and have great potential to be used in the clinic as diagnostic markers and therapeutic targets. Here, we review recent advances regarding the regulation of miRNAs in GI pacemaking cells, immune cells, and enteric neurons modulating pathophysiological mechanisms of DGBIs. This review aims to assess the impacts of miRNAs on the pathophysiological mechanisms of DGBIs, including GI dysmotility, impaired intestinal barrier function, gut immune dysfunction, and visceral hypersensitivity. We also summarize the therapeutic alternatives for gut microbial dysbiosis in DGBIs, highlighting the clinical insights and areas for further exploration. We further discuss the challenges in miRNA therapeutics and promising emerging approaches.<\/jats:p>","DOI":"10.3390\/jpm11101021","type":"journal-article","created":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T17:29:18Z","timestamp":1634059758000},"page":"1021","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Role of microRNAs in Disorders of Gut\u2013Brain Interactions: Clinical Insights and Therapeutic Alternatives"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5500-1949","authenticated-orcid":false,"given":"Rajan","family":"Singh","sequence":"first","affiliation":[{"name":"Department of Physiology and Cell Biology, Reno School of Medicine, University of Nevada, 1664 North Virginia Street, Reno, NV 89557, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2413-157X","authenticated-orcid":false,"given":"Hannah","family":"Zogg","sequence":"additional","affiliation":[{"name":"Department of Physiology and Cell Biology, Reno School of Medicine, University of Nevada, 1664 North Virginia Street, Reno, NV 89557, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0861-8334","authenticated-orcid":false,"given":"Seungil","family":"Ro","sequence":"additional","affiliation":[{"name":"Department of Physiology and Cell Biology, Reno School of Medicine, University of Nevada, 1664 North Virginia Street, Reno, NV 89557, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,10,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1053\/j.gastro.2020.04.014","article-title":"Worldwide prevalence and burden of functional gastrointestinal disorders, results of rome foundation global study","volume":"160","author":"Sperber","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/S0140-6736(20)32115-2","article-title":"Functional gastrointestinal disorders: Advances in understanding and management","volume":"396","author":"Black","year":"2020","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Tack, J., and Drossman, D.A. (2017). What\u2019s new in Rome IV?. Neurogastroenterol. Motil., 29.","DOI":"10.1111\/nmo.13053"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Keefer, L., Ko, C.W., and Ford, A.C. (2021). AGA clinical practice update on management of chronic gastrointestinal pain in disorders of gut-brain interaction: Expert review. Clin. Gastroenterol. Hepatol.","DOI":"10.1016\/j.cgh.2021.07.006"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1053\/j.gastro.2010.10.015","article-title":"Clinical features of idiopathic gastroparesis vary with sex, body mass, symptom onset, delay in gastric emptying, and gastroparesis severity","volume":"140","author":"Parkman","year":"2011","journal-title":"Gastroenterology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"267","DOI":"10.5056\/jnm18206","article-title":"High prevalence of slow transit constipation in patients with gastroparesis","volume":"25","author":"Zikos","year":"2019","journal-title":"J. Neurogastroenterol. Motil."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41575-020-0286-8","article-title":"Global burden of irritable bowel syndrome: Trends, predictions and risk factors","volume":"17","author":"Black","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/jgh.15032","article-title":"Marshall and warren lecture 2019: A paradigm shift in pathophysiological basis of irritable bowel syndrome and its implication on treatment","volume":"35","author":"Ghoshal","year":"2020","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/S0140-6736(20)30469-4","article-title":"Functional dyspepsia","volume":"396","author":"Ford","year":"2020","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1136\/gutjnl-2019-318712","article-title":"Gastroparesis: A turning point in understanding and treatment","volume":"68","author":"Grover","year":"2019","journal-title":"Gut"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"16014","DOI":"10.1038\/nrdp.2016.14","article-title":"Irritable bowel syndrome","volume":"2","author":"Enck","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"17081","DOI":"10.1038\/nrdp.2017.81","article-title":"Functional dyspepsia","volume":"3","author":"Enck","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41572-018-0038-z","article-title":"Gastroparesis","volume":"4","author":"Camilleri","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"334","DOI":"10.5056\/jnm17020","article-title":"Pros and cons while looking through an Asian window on the Rome IV criteria for irritable bowel syndrome: Pros","volume":"23","author":"Ghoshal","year":"2017","journal-title":"J. Neurogastroenterol. Motil."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/S0140-6736(20)31548-8","article-title":"Irritable bowel syndrome","volume":"396","author":"Ford","year":"2020","journal-title":"Lancet"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.5056\/jnm20149","article-title":"Gut microbial dysbiosis in the pathogenesis of gastrointestinal dysmotility and metabolic disorders","volume":"27","author":"Singh","year":"2021","journal-title":"J. Neurogastroenterol. Motil."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.immuni.2017.05.011","article-title":"The enteric network: Interactions between the immune and nervous systems of the gut","volume":"46","author":"Yoo","year":"2017","journal-title":"Immunity"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nrgastro.2012.168","article-title":"Regulation of gastrointestinal motility\u2014Insights from smooth muscle biology","volume":"9","author":"Sanders","year":"2012","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1053\/j.gastro.2011.01.046","article-title":"Cellular changes in diabetic and idiopathic gastroparesis","volume":"140","author":"Grover","year":"2011","journal-title":"Gastroenterology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1365-2982.2008.01109.x","article-title":"Interstitial cells of Cajal in health and disease","volume":"20","author":"Farrugia","year":"2008","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Grover, M., Gibbons, S.J., Nair, A.A., Bernard, C.E., Zubair, A.S., Eisenman, S.T., Wilson, L.A., Miriel, L., Pasricha, P.J., and Parkman, H.P. (2018). Transcriptomic signatures reveal immune dysregulation in human diabetic and idiopathic gastroparesis. BMC Med. Genom., 11.","DOI":"10.1186\/s12920-018-0379-1"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jcmgh.2016.01.003","article-title":"Intrinsic gastrointestinal macrophages: Their phenotype and role in gastrointestinal motility","volume":"2","author":"Cipriani","year":"2016","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1136\/gutjnl-2019-318747","article-title":"microRNA overexpression in slow transit constipation leads to reduced NaV1.5 current and altered smooth muscle contractility","volume":"69","author":"Mazzone","year":"2020","journal-title":"Gut"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: Target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1053\/j.gastro.2014.09.037","article-title":"MicroRNA 29 targets nuclear factor-kappaB-repressing factor and Claudin 1 to increase intestinal permeability","volume":"148","author":"Zhou","year":"2015","journal-title":"Gastroenterology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1136\/gutjnl-2013-306464","article-title":"Decreased miR-199 augments visceral pain in patients with IBS through translational upregulation of TRPV1","volume":"65","author":"Zhou","year":"2016","journal-title":"Gut"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1136\/gutjnl-2016-311477","article-title":"miR-16 and miR-125b are involved in barrier function dysregulation through the modulation of claudin-2 and cingulin expression in the jejunum in IBS with diarrhoea","volume":"66","author":"Martinez","year":"2017","journal-title":"Gut"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1053\/j.gastro.2020.12.062","article-title":"miR-10b-5p rescues diabetes and gastrointestinal dysmotility","volume":"160","author":"Singh","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1053\/j.gastro.2021.02.040","article-title":"The colonic mucosal MicroRNAs, MicroRNA-219a-5p, and MicroRNA-338-3p are downregulated in irritable bowel syndrome and are associated with barrier function and MAPK signaling","volume":"160","author":"Rankin","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1136\/gutjnl-2016-313525","article-title":"Novel insight in diarrhoea-predominant IBS: miRNAs modulate barrier function","volume":"66","author":"Wouters","year":"2017","journal-title":"Gut"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s12664-021-01159-7","article-title":"Micro-organic basis of functional gastrointestinal (GI) disorders: Role of microRNAs in GI pacemaking cells","volume":"40","author":"Singh","year":"2021","journal-title":"Indian J. Gastroenterol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.it.2016.05.003","article-title":"Cellular organization of neuroimmune interactions in the gastrointestinal tract","volume":"37","author":"Margolis","year":"2016","journal-title":"Trends Immunol."},{"key":"ref_33","first-page":"G75","article-title":"Neuroimmune interaction and the regulation of intestinal immune homeostasis","volume":"314","author":"Verheijden","year":"2018","journal-title":"Am. J. Physiol. Liver Physiol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Boeckxstaens, G.E., and Wouters, M.M. (2017). Neuroimmune factors in functional gastrointestinal disorders: A focus on irritable bowel syndrome. Neurogastroenterol. Motil., 29.","DOI":"10.1111\/nmo.13007"},{"key":"ref_35","first-page":"55","article-title":"Neuroimmune mechanisms in functional bowel disorders","volume":"69","author":"Wouters","year":"2011","journal-title":"Neth. J. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nrd4140","article-title":"MicroRNAs and other non-coding RNAs as targets for anticancer drug development","volume":"12","author":"Ling","year":"2013","journal-title":"Nat. Rev. Drug. Discov."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/17460441.2020.1690449","article-title":"Advances in the discovery of microRNA-based anticancer therapeutics: Latest tools and developments","volume":"15","author":"To","year":"2020","journal-title":"Expert Opin. Drug. Discov."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41573-021-00219-z","article-title":"Noncoding RNA therapeutics\u2014Challenges and potential solutions","volume":"20","author":"Winkle","year":"2021","journal-title":"Nat. Rev. Drug. Discov."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/s41467-019-08777-y","article-title":"Precise tuning of gene expression levels in mammalian cells","volume":"10","author":"Michaels","year":"2019","journal-title":"Nat. Commun"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00335-005-0066-3","article-title":"Mammalian microRNAs: A small world for fine-tuning gene expression","volume":"17","author":"Sevignani","year":"2006","journal-title":"Mamm. Genome"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Catalanotto, C., Cogoni, C., and Zardo, G. (2016). MicroRNA in control of gene expression: An overview of nuclear functions. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17101712"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"McGeary, S.E., Lin, K.S., Shi, C.Y., Pham, T.M., Bisaria, N., Kelley, G.M., and Bartel, D.P. (2019). The biochemical basis of microRNA targeting efficacy. Science, 366.","DOI":"10.1126\/science.aav1741"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"5944","DOI":"10.1093\/nar\/gkm641","article-title":"Tissue-dependent paired expression of miRNAs","volume":"35","author":"Ro","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature01957","article-title":"The nuclear RNase III Drosha initiates microRNA processing","volume":"425","author":"Lee","year":"2003","journal-title":"Nature"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1101\/gad.1158803","article-title":"Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs","volume":"17","author":"Yi","year":"2003","journal-title":"Genes Dev."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1038.e1","DOI":"10.1016\/j.cell.2018.07.040","article-title":"SnapShot: Unconventional miRNA functions","volume":"174","author":"Dragomir","year":"2018","journal-title":"Cell"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"14879","DOI":"10.1073\/pnas.0803230105","article-title":"A search for conserved sequences in coding regions reveals that the let-7 microRNA targets Dicer within its coding sequence","volume":"105","author":"Forman","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1038\/ng.3694","article-title":"General rules for functional microRNA targeting","volume":"48","author":"Kim","year":"2016","journal-title":"Nat. Genet."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nrg3853","article-title":"Competition between target sites of regulators shapes post-transcriptional gene regulation","volume":"16","author":"Jens","year":"2015","journal-title":"Nat. Rev. Genet."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"4696","DOI":"10.3892\/mmr.2020.11568","article-title":"Coexpression network analysis identified specific miRNAs and genes in association with slowtransit constipation","volume":"22","author":"Yu","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/gut.2009.203695","article-title":"Role of microRNA in IBS with increased gut permeability","volume":"59","author":"Vicario","year":"2010","journal-title":"Gut"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3389\/fpsyt.2020.00805","article-title":"Epigenetic mechanisms in irritable bowel syndrome","volume":"11","author":"Chang","year":"2020","journal-title":"Front. Psychiatry"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1478-811X-7-18","article-title":"Regulation of MicroRNA biogenesis: A miRiad of mechanisms","volume":"7","author":"Davis","year":"2009","journal-title":"Cell Commun. Signal."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/cdd.2014.112","article-title":"The complexity of miRNA-mediated repression","volume":"22","author":"Wilczynska","year":"2015","journal-title":"Cell Death Differ."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s12664-020-01143-7","article-title":"miR-222 regulates cell growth, apoptosis, and autophagy of interstitial cells of Cajal isolated from slow transit constipation rats by targeting c-kit","volume":"40","author":"Zheng","year":"2021","journal-title":"Indian J. Gastroenterol."},{"key":"ref_56","first-page":"7578","article-title":"miR-551b-5p increases intracellular Ca(2+) concentration but does not alter c-Kit expression in rat interstitial cells of Cajal","volume":"10","author":"Ke","year":"2017","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e2011","DOI":"10.1038\/cddis.2015.353","article-title":"Loss of serum response factor induces microRNA-mediated apoptosis in intestinal smooth muscle cells","volume":"6","author":"Park","year":"2015","journal-title":"Cell Death Dis."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"G980","DOI":"10.1152\/ajpgi.00152.2018","article-title":"Sepiapterin alleviates impaired gastric nNOS function in spontaneous diabetic female rodents through NRF2 mRNA turnover and miRNA biogenesis pathway","volume":"315","author":"Gangula","year":"2018","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1053\/j.gastro.2013.10.053","article-title":"MicroRNA 375 mediates palmitate-induced enteric neuronal damage and high-fat diet-induced delayed intestinal transit in mice","volume":"146","author":"Nezami","year":"2014","journal-title":"Gastroenterology"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3748\/wjg.v23.i1.93","article-title":"Role of mast cell-miR-490-5p in irritable bowel syndrome","volume":"23","author":"Ren","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"15268","DOI":"10.1002\/jcb.28794","article-title":"Silencing interleukin 1alpha underlies a novel inhibitory role of miR-181c-5p in alleviating low-grade inflammation of rats with irritable bowel syndrome","volume":"120","author":"Ji","year":"2019","journal-title":"J. Cell Biochem."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1007\/s10620-015-3612-1","article-title":"The relationship between colonic macrophages and MicroRNA-128 in the pathogenesis of slow transit constipation","volume":"60","author":"Liu","year":"2015","journal-title":"Dig. Dis. Sci."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"14680","DOI":"10.1038\/s41598-017-13982-0","article-title":"miR-16 and miR-103 impact 5-HT4 receptor signalling and correlate with symptom profile in irritable bowel syndrome","volume":"7","author":"Wohlfarth","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1093\/hmg\/ddn195","article-title":"First evidence for an association of a functional variant in the microRNA-510 target site of the serotonin receptor-type 3E gene with diarrhea predominant irritable bowel syndrome","volume":"17","author":"Kapeller","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.bbrc.2015.11.102","article-title":"MicroRNA-24 inhibits serotonin reuptake transporter expression and aggravates irritable bowel syndrome","volume":"469","author":"Liao","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/iub.2270","article-title":"microRNA-495 reduces visceral sensitivity in mice with diarrhea-predominant irritable bowel syndrome through suppression of the PI3K\/AKT signaling pathway via PKIB","volume":"72","author":"Fei","year":"2020","journal-title":"IUBMB Life"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"656","DOI":"10.5056\/jnm18037","article-title":"MicroRNA-200a targets cannabinoid receptor 1 and serotonin transporter to increase visceral hyperalgesia in diarrhea-predominant irritable bowel syndrome rats","volume":"24","author":"Hou","year":"2018","journal-title":"J. Neurogastroenterol. Motil."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3892\/etm.2020.9284","article-title":"Inhibition of miRNA-29a regulates intestinal barrier function in diarrhea-predominant irritable bowel syndrome by upregulating ZO-1 and CLDN1","volume":"20","author":"Zhu","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1136\/gut.2009.181834","article-title":"MicroRNA-29a regulates intestinal membrane permeability in patients with irritable bowel syndrome","volume":"59","author":"Zhou","year":"2010","journal-title":"Gut"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1053\/j.gastro.2011.07.005","article-title":"MicroRNA regulation of intestinal epithelial tight junction permeability","volume":"141","author":"Ye","year":"2011","journal-title":"Gastroenterology"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1159\/000486059","article-title":"MiR-144 increases intestinal permeability in IBS-D rats by targeting OCLN and ZO1","volume":"44","author":"Hou","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"15426","DOI":"10.1074\/jbc.M117.788596","article-title":"Commensal microbiota-induced microRNA modulates intestinal epithelial permeability through the small GTPase ARF4","volume":"292","author":"Nakata","year":"2017","journal-title":"J. Biol. Chem."},{"key":"ref_73","first-page":"6655900","article-title":"Serum exosomes derived from irritable bowel syndrome patient increase cell permeability via regulating miR-148b-5p\/RGS2 signaling in human colonic epithelium cells","volume":"2021","author":"Xing","year":"2021","journal-title":"Gastroenterol. Res. Pr."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1152\/physrev.00037.2013","article-title":"Interstitial cells: Regulators of smooth muscle function","volume":"94","author":"Sanders","year":"2014","journal-title":"Physiol. Rev."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1177\/0964528419829755","article-title":"Acupuncture protects the interstitial cells of Cajal by regulating miR-222 in a rat model of post-operative ileus","volume":"37","author":"Deng","year":"2019","journal-title":"Acupunct. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1053\/j.gastro.2011.03.058","article-title":"Serum response factor-dependent MicroRNAs regulate gastrointestinal smooth muscle cell phenotypes","volume":"141","author":"Park","year":"2011","journal-title":"Gastroenterology"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"193","DOI":"10.5056\/jnm15183","article-title":"Multi-phenotypic role of serum response factor in the gastrointestinal system","volume":"22","author":"Ro","year":"2016","journal-title":"J. Neurogastroenterol. Motil."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/1756283X11415892","article-title":"Targeting ion channels for the treatment of gastrointestinal motility disorders","volume":"5","author":"Beyder","year":"2012","journal-title":"Ther. Adv. Gastroenterol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1053\/gast.2002.30346","article-title":"Sodium current in human jejunal circular smooth muscle cells","volume":"122","author":"Holm","year":"2002","journal-title":"Gastroenterology"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.trsl.2012.12.004","article-title":"MicroRNA regulation of cardiac conduction and arrhythmias","volume":"161","author":"Kim","year":"2013","journal-title":"Transl. Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/s41583-018-0041-0","article-title":"Enteric nervous system development: What could possibly go wrong?","volume":"19","author":"Rao","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41575-020-0271-2","article-title":"Enteric nervous system: Sensory transduction, neural circuits and gastrointestinal motility","volume":"17","author":"Spencer","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3233\/JAD-150395","article-title":"miRNAs: Key players in neurodegenerative disorders and epilepsy","volume":"48","author":"Karnati","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/s41575-020-00385-2","article-title":"Disorders of the enteric nervous system\u2014A holistic view","volume":"18","author":"Niesler","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_85","first-page":"539","article-title":"Immune activation in functional gastrointestinal disorders","volume":"15","author":"Burns","year":"2019","journal-title":"Gastroenterol. Hepatol. (N. Y.)"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1111\/eci.12548","article-title":"Immune dysregulation in the functional gastrointestinal disorders","volume":"45","author":"Keely","year":"2015","journal-title":"Eur. J. Clin. Invest."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"349","DOI":"10.5056\/jnm.2011.17.4.349","article-title":"The immune system in irritable bowel syndrome","volume":"17","author":"Barbara","year":"2011","journal-title":"J. Neurogastroenterol. Motil."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/gutjnl-2015-309151","article-title":"The role of mast cells in functional GI disorders","volume":"65","author":"Wouters","year":"2016","journal-title":"Gut"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nri2708","article-title":"Physiological and pathological roles for microRNAs in the immune system","volume":"10","author":"Rao","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.canlet.2018.05.020","article-title":"MiRNAs: Dynamic regulators of immune cell functions in inflammation and cancer","volume":"431","author":"Hirschberger","year":"2018","journal-title":"Cancer Lett."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1084\/jem.20101823","article-title":"miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice","volume":"208","author":"Boldin","year":"2011","journal-title":"J. Exp. Med."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.immuni.2009.06.024","article-title":"The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs","volume":"31","author":"Androulidaki","year":"2009","journal-title":"Immunity"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"28929","DOI":"10.1074\/jbc.M702633200","article-title":"A cellular micro-RNA, let-7i, regulates Toll-like receptor 4 expression and contributes to cholangiocyte immune responses against Cryptosporidium parvum infection","volume":"282","author":"Chen","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1126\/science.1139253","article-title":"Requirement of bic\/microRNA-155 for normal immune function","volume":"316","author":"Rodriguez","year":"2007","journal-title":"Science"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1053\/j.gastro.2016.02.028","article-title":"The intestinal microenvironment and functional gastrointestinal disorders","volume":"150","author":"Barbara","year":"2016","journal-title":"Gastroenterology"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1136\/gutjnl-2020-321530","article-title":"Effect of resolvins on sensitisation of TRPV1 and visceral hypersensitivity in IBS","volume":"70","author":"Perna","year":"2021","journal-title":"Gut"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/nmo.12315","article-title":"Tight junctions and IBS\u2014The link between epithelial permeability, low-grade inflammation, and symptom generation?","volume":"26","author":"Piche","year":"2014","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.gie.2012.11.006","article-title":"Breaks in the wall: Increased gaps in the intestinal epithelium of irritable bowel syndrome patients identified by confocal laser endomicroscopy (with videos)","volume":"77","author":"Turcotte","year":"2013","journal-title":"Gastrointest. Endosc."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1053\/j.gastro.2014.07.046","article-title":"Confocal endomicroscopy shows food-associated changes in the intestinal mucosa of patients with irritable bowel syndrome","volume":"147","author":"Schuppan","year":"2014","journal-title":"Gastroenterology"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1177\/0148607115587330","article-title":"Glutamine restores tight junction protein claudin-1 expression in colonic mucosa of patients with diarrhea-predominant irritable bowel syndrome","volume":"40","author":"Bertrand","year":"2016","journal-title":"JPEN J. Parenter. Enter. Nutr."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"e944446","DOI":"10.4161\/21688362.2014.944446","article-title":"MicroRNAs regulate tight junction proteins and modulate epithelial\/endothelial barrier functions","volume":"2","author":"Cichon","year":"2014","journal-title":"Tissue Barriers"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nrgastro.2013.105","article-title":"Serotonin signalling in the gut\u2014Functions, dysfunctions and therapeutic targets","volume":"10","author":"Mawe","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1053\/j.gastro.2021.02.060","article-title":"Serotonin deficiency is associated with delayed gastric emptying","volume":"160","author":"Wei","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_104","first-page":"268","article-title":"Serotonin is a sword and a shield of the bowel: Serotonin plays offense and defense","volume":"123","author":"Gershon","year":"2012","journal-title":"Trans. Am. Clin. Climatol. Assoc."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2036.2004.02180.x","article-title":"Review article: Serotonin receptors and transporters\u2014Roles in normal and abnormal gastrointestinal motility","volume":"20","author":"Gershon","year":"2004","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1053\/j.gastro.2021.04.040","article-title":"Colonic moatility is improved by the activation of 5-HT2B receptors on interstitial cells of Cajal in diabetic mice","volume":"161","author":"Jin","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_107","first-page":"3250","article-title":"The pro-inflammatory cytokine 14-3-3epsilon is a ligand of CD13 in cartilage","volume":"128","author":"Nefla","year":"2015","journal-title":"J. Cell Sci."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.yexmp.2014.04.009","article-title":"Elevated circulating miR-150 and miR-342-3p in patients with irritable bowel syndrome","volume":"96","author":"Fourie","year":"2014","journal-title":"Exp. Mol. Pathol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1517\/14712598.2011.577060","article-title":"miRNA-based therapies for the irritable bowel syndrome","volume":"11","author":"Zhou","year":"2011","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1007\/s10620-020-06096-7","article-title":"Exosomal hsa-miR-933 in gastric juice as a potential biomarker for functional dyspepsia","volume":"65","author":"Tanaka","year":"2020","journal-title":"Dig. Dis. Sci."},{"key":"ref_111","first-page":"4875","article-title":"Effect of miRNA-19a on gastrointestinal motility in rats with functional dyspepsia","volume":"15","author":"Deng","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s00535-012-0576-1","article-title":"Genetic polymorphism of pri-microRNA 325, targeting SLC6A4 3\u2032-UTR, is closely associated with the risk of functional dyspepsia in Japan","volume":"47","author":"Arisawa","year":"2012","journal-title":"J. Gastroenterol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1053\/j.gastro.2010.08.044","article-title":"Dysfunctional gastric emptying with down-regulation of muscle-specific microRNAs in Helicobacter pylori-infected mice","volume":"140","author":"Saito","year":"2011","journal-title":"Gastroenterology"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Narayanan, S.P., O\u2019Brien, D., Sharma, M., Miller, K., Adams, P., Passos, J.F., Eirin, A., Ordog, T., and Bharucha, A.E. (2021). Duodenal mucosal mitochondrial gene expression is associated with delayed gastric emptying in diabetic gastroenteropathy. JCI Insight, 6.","DOI":"10.1172\/jci.insight.143596"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"2617432","DOI":"10.1155\/2018\/2617432","article-title":"Aberrantly expressed genes and miRNAs in slow transit constipation based on RNA-Seq analysis","volume":"2018","author":"Zhao","year":"2018","journal-title":"Biomed. Res. Int."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/MEG.0000000000000511","article-title":"Functional dyspepsia is associated with GNbeta3 C825T and CCK-AR T\/C polymorphism","volume":"28","author":"Singh","year":"2016","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/ncpgasthep0717","article-title":"Mechanisms of disease: Genetics of functional gastrointestinal disorders\u2014Searching the genes that matter","volume":"4","author":"Adam","year":"2007","journal-title":"Nat. Clin. Pr. Gastroenterol. Hepatol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/jcp.21246","article-title":"Mitogenic signaling pathways induced by G protein-coupled receptors","volume":"213","author":"Rozengurt","year":"2007","journal-title":"J. Cell Physiol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.regpep.2009.03.012","article-title":"Opioid receptors in the gastrointestinal tract","volume":"155","author":"Holzer","year":"2009","journal-title":"Regul. Pept."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"G361","DOI":"10.1152\/ajpgi.00144.2017","article-title":"Role of G protein-coupled receptors-microRNA interactions in gastrointestinal pathophysiology","volume":"313","author":"Law","year":"2017","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1172\/JCI30085","article-title":"Corticotropin-releasing factor receptors and stress-related alterations of gut motor function","volume":"117","author":"Tache","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"e13688","DOI":"10.1111\/nmo.13688","article-title":"micro-opioid receptor, beta-endorphin, and cannabinoid receptor-2 are increased in the colonic mucosa of irritable bowel syndrome patients","volume":"31","author":"Dothel","year":"2019","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1210\/me.2012-1357","article-title":"miR-449a contributes to glucocorticoid-induced CRF-R1 downregulation in the pituitary during stress","volume":"27","author":"Nemoto","year":"2013","journal-title":"Mol. Endocrinol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"E781","DOI":"10.1152\/ajpendo.00616.2011","article-title":"Increased expression of miR-325-3p by urocortin 2 and its involvement in stress-induced suppression of LH secretion in rat pituitary","volume":"302","author":"Nemoto","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1365-2982.2005.00640.x","article-title":"Alvimopan, a selective peripherally acting mu-opioid antagonist","volume":"17","author":"Camilleri","year":"2005","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s00535-013-0753-x","article-title":"Physiology, signaling, and pharmacology of opioid receptors and their ligands in the gastrointestinal tract: Current concepts and future perspectives","volume":"49","author":"Sobczak","year":"2014","journal-title":"J. Gastroenterol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"10251","DOI":"10.1523\/JNEUROSCI.2419-10.2010","article-title":"Regulation of opioid tolerance by let-7 family microRNA targeting the mu opioid receptor","volume":"30","author":"He","year":"2010","journal-title":"J. Neurosci."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1124\/mol.113.089292","article-title":"Morphine regulates expression of mu-opioid receptor MOR-1A, an intron-retention carboxyl terminal splice variant of the mu-opioid receptor (OPRM1) gene via miR-103\/miR-107","volume":"85","author":"Lu","year":"2014","journal-title":"Mol. Pharmacol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/j.1532-2149.2012.00197.x","article-title":"Regulation of mu-opioid type 1 receptors by microRNA134 in dorsal root ganglion neurons following peripheral inflammation","volume":"17","author":"Ni","year":"2013","journal-title":"Eur. J. Pain."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.chom.2015.12.005","article-title":"The host shapes the gut microbiota via fecal MicroRNA","volume":"19","author":"Liu","year":"2016","journal-title":"Cell Host Microbe"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3920\/BM2017.0013","article-title":"Faecal microRNAs: Indicators of imbalance at the host-microbe interface?","volume":"9","author":"Moloney","year":"2018","journal-title":"Benef. Microbes"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"176","DOI":"10.15698\/mic2016.04.492","article-title":"Control of the gut microbiome by fecal microRNA","volume":"3","author":"Liu","year":"2016","journal-title":"Microb. Cell"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.tim.2018.10.011","article-title":"MicroRNAs at the Host-Bacteria Interface: Host Defense or Bacterial Offense","volume":"27","author":"Aguilar","year":"2019","journal-title":"Trends Microbiol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"604462","DOI":"10.3389\/fmicb.2020.604462","article-title":"Probiotics and MicroRNA: Their roles in the host-microbe interactions","volume":"11","author":"Zhao","year":"2020","journal-title":"Front. Microbiol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nrgastro.2017.54","article-title":"Gut microbiota\u2014At the intersection of everything?","volume":"14","author":"Cani","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1126\/science.1104816","article-title":"Host-bacterial mutualism in the human intestine","volume":"307","author":"Backhed","year":"2005","journal-title":"Science"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1056\/NEJMra1600266","article-title":"The human intestinal microbiome in health and disease","volume":"375","author":"Lynch","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrgastro.2016.135","article-title":"Gut microbiota: Changes in gut microbes and host metabolism: Squaring the circle?","volume":"13","author":"Cani","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/nm.4185","article-title":"Signals from the gut microbiota to distant organs in physiology and disease","volume":"22","author":"Schroeder","year":"2016","journal-title":"Nat. Med."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1572-0241.2005.40312.x","article-title":"Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR","volume":"100","author":"Malinen","year":"2005","journal-title":"Am. J. Gastroenterol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1007\/s10620-015-3607-y","article-title":"Fecal microbiota in patients with irritable bowel syndrome compared with healthy controls using real-time polymerase chain reaction: An evidence of dysbiosis","volume":"60","author":"Shukla","year":"2015","journal-title":"Dig. Dis. Sci."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1053\/j.gastro.2016.09.049","article-title":"Identification of an intestinal microbiota signature associated with severity of irritable bowel syndrome","volume":"152","author":"Tap","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1053\/j.gastro.2019.03.049","article-title":"Gut microbiota in patients with irritable bowel syndrome\u2014A systematic review","volume":"157","author":"Pittayanon","year":"2019","journal-title":"Gastroenterology"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s12664-018-0901-6","article-title":"A randomized double-blind placebo-controlled trial showing rifaximin to improve constipation by reducing methane production and accelerating colon transit: A pilot study","volume":"37","author":"Ghoshal","year":"2018","journal-title":"Indian J. Gastroenterol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s12325-018-0673-5","article-title":"A review of microbiota and irritable bowel syndrome: Future in therapies","volume":"35","author":"Vicario","year":"2018","journal-title":"Adv. Ther."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1136\/gutjnl-2016-312574","article-title":"Dyspepsia and the microbiome: Time to focus on the small intestine","volume":"66","author":"Zhong","year":"2017","journal-title":"Gut"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"e000144","DOI":"10.1136\/bmjgast-2017-000144","article-title":"Alteration in the gastric microbiota and its restoration by probiotics in patients with functional dyspepsia","volume":"4","author":"Igarashi","year":"2017","journal-title":"BMJ Open Gastroenterol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1152\/physrev.00045.2009","article-title":"Gut microbiota in health and disease","volume":"90","author":"Sekirov","year":"2010","journal-title":"Physiol. Rev."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1152\/physrev.1990.70.2.567","article-title":"Energy contributions of volatile fatty acids from the gastrointestinal tract in various species","volume":"70","author":"Bergman","year":"1990","journal-title":"Physiol. Rev."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"16767","DOI":"10.1073\/pnas.0808567105","article-title":"Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41","volume":"105","author":"Samuel","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"e14513","DOI":"10.1097\/MD.0000000000014513","article-title":"Alterations in fecal short-chain fatty acids in patients with irritable bowel syndrome: A systematic review and meta-analysis","volume":"98","author":"Sun","year":"2019","journal-title":"Medicine"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1096\/fj.14-259598","article-title":"Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells","volume":"29","author":"Reigstad","year":"2015","journal-title":"FASEB J."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1038\/s41564-019-0540-4","article-title":"Intestinal serotonin and fluoxetine exposure modulate bacterial colonization in the gut","volume":"4","author":"Fung","year":"2019","journal-title":"Nat. Microbiol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.chom.2014.09.001","article-title":"Discovery and characterization of gut microbiota decarboxylases that can produce the neurotransmitter tryptamine","volume":"16","author":"Williams","year":"2014","journal-title":"Cell Host Microbe"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.chom.2018.05.004","article-title":"Gut microbiota-produced tryptamine activates an epithelial G-protein-coupled receptor to increase colonic secretion","volume":"23","author":"Bhattarai","year":"2018","journal-title":"Cell Host Microbe"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s11910-017-0802-6","article-title":"Microbiota-brain-gut axis and neurodegenerative diseases","volume":"17","author":"Quigley","year":"2017","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nrgastro.2009.35","article-title":"Principles and clinical implications of the brain-gut-enteric microbiota axis","volume":"6","author":"Rhee","year":"2009","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_158","first-page":"203","article-title":"The gut-brain axis: Interactions between enteric microbiota, central and enteric nervous systems","volume":"28","author":"Carabotti","year":"2015","journal-title":"Ann. Gastroenterol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.smim.2007.04.002","article-title":"Paneth cells, defensins, and the commensal microbiota: A hypothesis on intimate interplay at the intestinal mucosa","volume":"19","author":"Salzman","year":"2007","journal-title":"Semin. Immunol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41583-020-00381-0","article-title":"Gut microbial molecules in behavioural and neurodegenerative conditions","volume":"21","author":"Needham","year":"2020","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1053\/j.gastro.2016.02.027","article-title":"Biopsychosocial aspects of functional gastrointestinal disorders","volume":"150","author":"Crowell","year":"2016","journal-title":"Gastroenterology"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/apt.15325","article-title":"Systematic review with meta-analysis: The prevalence of anxiety and depression in patients with irritable bowel syndrome","volume":"50","author":"Zamani","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_163","first-page":"39","article-title":"Probiotic therapy for irritable bowel syndrome","volume":"6","author":"Aragon","year":"2010","journal-title":"Gastroenterol. Hepatol. (N. Y.)"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"e000314","DOI":"10.1136\/bmjgast-2019-000314","article-title":"Gasseri strain (LG21) for the upper gastrointestinal tract acting through improvement of indigenous microbiota","volume":"6","author":"Koga","year":"2019","journal-title":"BMJ Open Gastroenterol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s13167-019-00190-1","article-title":"Can tailored nanoceria act as a prebiotic? Report on improved lipid profile and gut microbiota in obese mice","volume":"10","author":"Bubnov","year":"2019","journal-title":"EPMA J."},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Wang, X., Gibson, G.R., Sailer, M., Theis, S., and Rastall, R.A. (2020). Prebiotics inhibit proteolysis by gut bacteria in a host diet-dependent manner: A three-stage continuous in vitro gut model experiment. Appl. Environ. Microbiol., 86.","DOI":"10.1128\/AEM.02730-19"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s13167-018-0132-z","article-title":"Specific properties of probiotic strains: Relevance and benefits for the host","volume":"9","author":"Bubnov","year":"2018","journal-title":"EPMA J."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41575-018-0061-2","article-title":"You are what you eat: Diet, health and the gut microbiota","volume":"16","author":"Zmora","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/d41586-019-03704-z","article-title":"Food for thought about manipulating gut bacteria","volume":"577","author":"Delzenne","year":"2020","journal-title":"Nature"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nature18846","article-title":"Diet-microbiota interactions as moderators of human metabolism","volume":"535","author":"Sonnenburg","year":"2016","journal-title":"Nature"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s12664-019-01002-0","article-title":"All that a physician should know about FODMAPs","volume":"38","author":"Mehtab","year":"2019","journal-title":"Indian J. Gastroenterol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1053\/j.gastro.2020.10.058","article-title":"Functional gastrointestinal disorders and the microbiome\u2014What is the best strategy for moving microbiome-based therapies for functional gastrointestinal disorders into the clinic?","volume":"160","author":"Mars","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1136\/gutjnl-2017-313750","article-title":"The low FODMAP diet: Recent advances in understanding its mechanisms and efficacy in IBS","volume":"66","author":"Staudacher","year":"2017","journal-title":"Gut"},{"key":"ref_174","doi-asserted-by":"crossref","unstructured":"Altobelli, E., Del Negro, V., Angeletti, P.M., and Latella, G. (2017). Low-FODMAP diet improves irritable bowel syndrome symptoms: A meta-analysis. Nutrients, 9.","DOI":"10.3390\/nu9090940"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3389\/fnut.2019.00047","article-title":"The effects of vegetarian and vegan diets on gut microbiota","volume":"6","author":"Tomova","year":"2019","journal-title":"Front. Nutr."},{"key":"ref_176","first-page":"114","article-title":"How close are miRNAs from clinical practice? A perspective on the diagnostic and therapeutic market","volume":"30","author":"Bonneau","year":"2019","journal-title":"EJIFCC"},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Brennecke, J., Stark, A., Russell, R.B., and Cohen, S.M. (2005). Principles of microRNA-target recognition. PLoS Biol., 3.","DOI":"10.1371\/journal.pbio.0030085"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ng1536","article-title":"Combinatorial microRNA target predictions","volume":"37","author":"Krek","year":"2005","journal-title":"Nat. Genet."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/wrna.1363","article-title":"Exosome-mediated small RNA delivery for gene therapy","volume":"7","author":"Zhou","year":"2016","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13578-019-0282-2","article-title":"Exosomes: Biogenesis, biologic function and clinical potential","volume":"9","author":"Zhang","year":"2019","journal-title":"Cell Biosci."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.4155\/fmc.14.116","article-title":"miRNA-based therapies: Strategies and delivery platforms for oligonucleotide and non-oligonucleotide agents","volume":"6","author":"Baumann","year":"2014","journal-title":"Futur. Med. Chem."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"14754","DOI":"10.1021\/jacs.0c04928","article-title":"The interaction of phosphorothioate-containing RNA targeted drugs with proteins is a critical determinant of the therapeutic effects of these agents","volume":"142","author":"Crooke","year":"2020","journal-title":"J. Am. Chem. Soc."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41434-020-0156-6","article-title":"Optimization of antisense-mediated exon skipping for Duchenne muscular dystrophy","volume":"27","author":"Dzierlega","year":"2020","journal-title":"Gene Ther."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nbt.3802","article-title":"Overcoming cellular barriers for RNA therapeutics","volume":"35","author":"Dowdy","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/wrna.1120","article-title":"Potential pitfalls in microRNA profiling","volume":"3","author":"Chugh","year":"2012","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/nmeth0910-687","article-title":"MicroRNA profiling: Separating signal from noise","volume":"7","author":"Baker","year":"2010","journal-title":"Nat. Methods"},{"key":"ref_187","doi-asserted-by":"crossref","unstructured":"Wright, C., Rajpurohit, A., Burke, E.E., Williams, C., Collado-Torres, L., Kimos, M., Brandon, N.J., Cross, A.J., Jaffe, A.E., and Weinberger, D.R. (2019). Comprehensive assessment of multiple biases in small RNA sequencing reveals significant differences in the performance of widely used methods. BMC Genom., 20.","DOI":"10.1186\/s12864-019-5870-3"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"4316","DOI":"10.1038\/s41467-021-24611-w","article-title":"Single-cell microRNA sequencing method comparison and application to cell lines and circulating lung tumor cells","volume":"12","author":"Hucker","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1136\/gutjnl-2014-307891","article-title":"MicroRNAs: New players in IBD","volume":"64","author":"Kalla","year":"2015","journal-title":"Gut"},{"key":"ref_190","doi-asserted-by":"crossref","unstructured":"Riffo-Campos, A.L., Riquelme, I., and Brebi-Mieville, P. (2016). Tools for sequence-based miRNA target prediction: What to choose?. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17121987"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1053\/j.gastro.2013.01.047","article-title":"Complex interactions among diet, gastrointestinal transit, and gut microbiota in humanized mice","volume":"144","author":"Kashyap","year":"2013","journal-title":"Gastroenterology"},{"key":"ref_192","doi-asserted-by":"crossref","unstructured":"Tarallo, S., Ferrero, G., De Filippis, F., Francavilla, A., Pasolli, E., Panero, V., Cordero, F., Segata, N., Grioni, S., and Pensa, R.G. (2021). Stool microRNA profiles reflect different dietary and gut microbiome patterns in healthy individuals. Gut.","DOI":"10.1136\/gutjnl-2021-325168"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.chom.2018.10.001","article-title":"Plant-derived exosomal MicroRNAs shape the gut microbiota","volume":"24","author":"Teng","year":"2018","journal-title":"Cell Host Microbe"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/nrgastro.2016.19","article-title":"Gut microbiota: Host faecal miRNA regulates gut microbiota","volume":"13","author":"Thomas","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/jgh3.12528","article-title":"Gut microbiota dysbiosis in functional gastrointestinal disorders: Underpinning the symptoms and pathophysiology","volume":"5","author":"Wei","year":"2021","journal-title":"JGH Open"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.cell.2020.08.007","article-title":"Longitudinal multi-omics reveals subset-specific mechanisms underlying irritable bowel syndrome","volume":"182","author":"Mars","year":"2020","journal-title":"Cell"}],"container-title":["Journal of Personalized Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4426\/11\/10\/1021\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:12:02Z","timestamp":1760166722000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4426\/11\/10\/1021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,12]]},"references-count":196,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["jpm11101021"],"URL":"https:\/\/doi.org\/10.3390\/jpm11101021","relation":{},"ISSN":["2075-4426"],"issn-type":[{"value":"2075-4426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,12]]}}}